Stock research
Ventas, Inc. (VTR) Stock Research
Ventas is a healthcare REIT owning senior housing, medical offices, and research facilities.
Ventas, Inc. reported revenue of $5.8B for the fiscal year ended December 31, 2025. Source: Form 10-K filed February 6, 2026
SEC data as of
- Ticker
- VTR
- Exchange
- NYSE
- Sector
- Real
- Founded
- —
Reported SEC XBRL figures. Each metric’s period and original filing are listed below.
Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.
About Ventas
- Exchange
- NYSE: VTR
- Sector
- Real Estate
- SEC industry
- Real Estate Investment Trusts (SIC 6798)
- Fiscal year end
- December 31
VTR key financials
Reported figures from Ventas, Inc.'s filings, pulled directly from SEC XBRL data rather than a third-party terminal. Each row links to the filing it came from.
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $5.8B | 2025-01-01 – 2025-12-31 | SEC filing |
| Operating cash flow | $1.6B | 2025-01-01 – 2025-12-31 | SEC filing |
| Diluted EPS | $0.54 | 2025-01-01 – 2025-12-31 | SEC filing |
| Shares outstanding | 475M | As of 2026-02-03 | SEC filing |
Values are as tagged by the issuer in XBRL. Revenue for banks and insurers is net of interest expense where that is the reported line. Fiscal years that do not follow the calendar are shown by their period-end date. No price, market cap, or valuation multiple is shown because Yield Theory does not republish unlicensed market data.
Diluted EPS is the earnings figure behind the price-to-earnings ratio; the P/E multiple compression calculator shows how a change in that multiple moves a share price. Shares outstanding multiplied by the share price gives market capitalization.
What investors should watch in VTR
Ventas, Inc. sits in Real Estate. REITs across offices, data centers, industrial, and residential — the most rate-sensitive corner of the equity market. We have not yet written company-specific drivers for VTR; the forces that matter most for the sector are:
- ◆Long-term interest rates and cap rates
- ◆Occupancy and rent growth by property type
- ◆Data-center demand from AI workloads
- ◆Refinancing walls and commercial credit
VTR primary sources
- Latest annual report: Form 10-K filed February 6, 2026
- Latest quarterly report: Form 10-Q filed July 30, 2026
- All VTR filings on SEC EDGAR
How we source and review company pages: research methodology.
Congressional trading in VTR
| Politician | Trade date | Type | Owner | Amount | Source |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | Purchase | Self | $1,001 - $15,000 | Filing #fda235b3-bad7-4637-8fa1-053f354d929c |
| Gilbert Cisneros | 2026-01-09 | Sale | Self | $1,001 - $15,000 | Filing #20033983 |
| Gilbert Cisneros | 2025-11-12 | Purchase | Self | $1,001 - $15,000 | Filing #20033619 |
All verified VTR congressional disclosures
Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.
Compare VTR with similar companies
Ventas peers
VTR — frequently asked questions
What does Ventas, Inc. do?
Ventas is a healthcare REIT owning senior housing, medical offices, and research facilities.
What were VTR's latest reported annual revenue and net income?
Ventas, Inc. reported revenue of $5.8B for the fiscal year ended December 31, 2025. The figures come from Ventas, Inc.'s SEC XBRL filings.
When does Ventas, Inc.'s fiscal year end?
The SEC lists Ventas, Inc.'s fiscal year end as December 31.
Do members of Congress trade VTR?
The current verified House and Senate snapshot contains 3 transaction rows for VTR, each linked to the original filing.
Is VTR a good investment?
This page does not rate VTR as a buy or sell. It sets out what Ventas, Inc. reports, what investors should watch and the questions a thesis has to answer, with links to the SEC filings. It is research, not investment advice.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
What do the VTR numbers leave unanswered?
Financials describe the business. The next question is which assumptions an investment thesis depends on. Explore the member reports below for analysis of catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included